Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.37 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.37 |
| ▸ | HTR2A | P28223 | 2/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10343902 | 0.83 | TAAR1 (0.48) | LMNATAAR1HTR2AHRH1 | |
| SCHEMBL21625270 | 0.83 | AOC3 (0.42) | LMNATRPA1TAAR1HTR2AHRH1 | |
| SCHEMBL1254320 | 0.83 | LMNA (0.48) | LMNAMIFTRPA1HKDC1AOC3 | |
| SCHEMBL8974394 | 0.81 | LMNA (0.44) | LMNAMIFTRPA1TAAR1HTR2A | |
| SCHEMBL11967590 | 0.81 | MAOB (0.43) | LMNAMIFTRPA1POLB | |
| SCHEMBL3144258 | 0.79 | LMNA (0.48) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL28607657 | 0.79 | LMNA (0.48) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL23728346 | 0.78 | ESR1 (0.54) | LMNATAAR1TDP1 | |
| SCHEMBL10012533 | 0.77 | LMNA (0.46) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL218804 | 0.77 | LMNA (0.46) | LMNAMIFTRPA1HKDC1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230123589-A1 | MOLECULAR MOBILITY ENHANCER OR MOLECULAR DRYING ENHANCER | TEKDRY INTERNATIONAL, INC. | 2023-04-20 | — | — | US | disclosed |
| EP-4097386-A1 | MOLECULAR MOBILITY ENHANCER OR MOLECULAR DRYING ENHANCER | TekDry International, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| WO-2021154959-A1 | MOLECULAR MOBILITY ENHANCER OR MOLECULAR DRYING ENHANCER | TEKDRY INTERNATIONAL, INC. (US) | 2021-08-05 | — | — | WO | disclosed |
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20060083945-A1 | New luminescent compositions and their uses | HITACHI CHEMICAL CO. LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060083945-A1 | New luminescent compositions and their uses | OCIAD1, NLRP3, OCIAD2 | LMNA 3456/4885MIF 3319/4885TRPA1 91/4885 |
| US-20230123589-A1 | MOLECULAR MOBILITY ENHANCER OR MOLECULAR DRYING ENHANCER | SNRPE, MTREX, MMP20 | LMNA 3216/4885MIF 29/4885TRPA1 453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.